Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disopyramide: six years' experience.

R R Wilson, A G Wallace

    Angiology
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Oral disopyramide is an effective treatment for ventricular arrhythmias. Clinical experience has improved dosing and patient selection for this medication.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Embedding thin blocks in correct orientation and sequence.

    Bulletin. International Association of Medical Museums·2014
    Same author

    The Homogeneous Relations of Physicians and Pharmacists.

    Journal of the National Medical Association·2010
    Same author

    Population genetic structure of the round stingray Urobatis halleri (Elasmobranchii: Rajiformes) in southern California and the Gulf of California.

    Journal of fish biology·2010
    Same author

    Genetics and science in the U.S.S.R.

    British medical journal·2010
    Same author

    Radiological use of fast protons.

    Radiology·2010
    Same author

    Mono-energetic protons from a cyclotron.

    The Review of scientific instruments·2010
    Same journal

    Refining Phenotype-Based Interpretation of SGLT2 Inhibitors After AMI Without Heart Failure.

    Angiology·2026
    Same journal

    Response to: "Integrating Noninvasive Liver Indices into Risk Stratification of Myocardial Infarction With Non-Obstructive Coronary Arteries".

    Angiology·2026
    Same journal

    Response to: "Beyond Traditional Risk Markers: Is FIB-4 Sufficient in MINOCA?"

    Angiology·2026
    Same journal

    Letter: Further Considerations on the Clinical Use of the Scottish Inflammatory Prognostic Score in STEMI No-Reflow Prediction.

    Angiology·2026
    Same journal

    Contextualizing Remodeling Endpoints in Endovascular Treatment for Symptomatic SISMAD.

    Angiology·2026
    Same journal

    <i>Response to the Letter to the Editor</i>: "Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction".

    Angiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Oral disopyramide has been FDA-approved for six years.
    • It is established in treating ventricular arrhythmias.

    Purpose of the Study:

    • To review recent therapeutic experiences with oral disopyramide.
    • To highlight advancements in its clinical application.

    Main Methods:

    • Review of clinical experience and literature.
    • Analysis of updated dosing guidelines.
    • Evaluation of patient selection criteria.

    Main Results:

    • Refined understanding of disopyramide's efficacy.
    • Improved dosing strategies.
    • Enhanced patient selection protocols.

    Conclusions:

    • Oral disopyramide remains a key therapy for ventricular arrhythmias.
    • Ongoing clinical experience refines its optimal use.